179 related articles for article (PubMed ID: 17437513)
21. Postmenopausal hormone therapy: who now takes it and do they differ from non-users?
Taylor AW; MacLennan AH; Avery JC
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):128-35. PubMed ID: 16638035
[TBL] [Abstract][Full Text] [Related]
22. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of gallstones and gallbladder disease in Canadian Micmac Indian women.
Williams CN; Johnston JL; Weldon KL
Can Med Assoc J; 1977 Oct; 117(7):758-60. PubMed ID: 907946
[TBL] [Abstract][Full Text] [Related]
24. Menopausal hormone therapy does not play a major role in left ventricular hypertrophy.
Schwarz S; Obst A; Schwahn C; Völzke H; Schmidt CO; Dörr M; Felix SB; Dören M
Maturitas; 2010 Jun; 66(2):212-8. PubMed ID: 20409654
[TBL] [Abstract][Full Text] [Related]
25. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
26. Use of complementary medicinal therapies in West Pomerania: a population-based study.
Schwarz S; Messerschmidt H; Völzke H; Hoffmann W; Lucht M; Dören M
Climacteric; 2008 Apr; 11(2):124-34. PubMed ID: 18365855
[TBL] [Abstract][Full Text] [Related]
27. Is there a link between oestrogen therapy and gallbladder disease?
Dhiman RK; Chawla YK
Expert Opin Drug Saf; 2006 Jan; 5(1):117-29. PubMed ID: 16370961
[TBL] [Abstract][Full Text] [Related]
28. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005.
Cho GJ; Park HT; Shin JH; Kim T; Hur JY; Kim YT; Lee KW; Kim SH
Menopause; 2009; 16(5):998-1003. PubMed ID: 19407665
[TBL] [Abstract][Full Text] [Related]
29. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
Yuk JS; Park JY
PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of risk factors and symptoms associated with menopause in Spanish women.
Pérez JA; Garcia FC; Palacios S; Pérez M
Maturitas; 2009 Jan; 62(1):30-6. PubMed ID: 19010615
[TBL] [Abstract][Full Text] [Related]
31. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Anagnostis EA
J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
[TBL] [Abstract][Full Text] [Related]
32. Knowledge of Bahraini women about the menopause and hormone therapy: implications for health-care policy.
Jassim GA; Al-Shboul QM
Climacteric; 2009 Feb; 12(1):38-48. PubMed ID: 19051101
[TBL] [Abstract][Full Text] [Related]
33. Risk perception in women: a focus on menopause.
Deeks A; Zoungas S; Teede H
Menopause; 2008; 15(2):304-9. PubMed ID: 18090036
[TBL] [Abstract][Full Text] [Related]
34. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
35. Menopausal symptoms in mid-life women in southern China.
Yang D; Haines CJ; Pan P; Zhang Q; Sun Y; Hong S; Tian F; Bai B; Peng X; Chen W; Yang X; Chen Y; Feng H; Zhao S; Lei H; Jiang Z; Ma X; Liao W
Climacteric; 2008 Aug; 11(4):329-36. PubMed ID: 18645699
[TBL] [Abstract][Full Text] [Related]
36. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract][Full Text] [Related]
37. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
[TBL] [Abstract][Full Text] [Related]
38. Quality of life impairment during the female menopausal transition is related to personal and partner factors.
Chedraui P; San Miguel G; Avila C
Gynecol Endocrinol; 2009 Feb; 25(2):130-5. PubMed ID: 19253110
[TBL] [Abstract][Full Text] [Related]
39. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
Haskell SG; Bean-Mayberry B; Gordon K
Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for goiter in a previously iodine-deficient region.
Völzke H; Schwahn C; Kohlmann T; Kramer A; Robinson DM; John U; Meng W
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):507-15. PubMed ID: 16235152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
